
    
      Patients will receive intravenous hydration, acetaminophen and diphenhydramine hydrochloride
      (or appropriate alternative regimen) approximately 30 minutes prior to UCB infusion with
      doses adjusted for subject age and weight unless otherwise specified in the specific
      treatment protocol. Additional treatments will vary with the specific use of the UCB cells as
      specified in institutional review board (IRB)-approved disease-specific protocols at the
      University of Minnesota.
    
  